Bionano Genomics (BNGO) Current Assets (2017 - 2026)
Bionano Genomics (BNGO) posted Current Assets of $39.0 million for Q1 2026, down 14.13% sequentially from $45.4 million in Q4 2025, and down 13.25% YoY from $44.9 million in Q1 2025.
Bionano Genomics (BNGO) Current Assets (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Current Assets for 10 years, with the latest figure at $39.0 million in Q1 2026.
- Quarterly Current Assets fell 13.25% year-over-year to $39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.0 million (down 13.25% YoY) and the FY2025 annual result came in at $45.4 million, up 14.93% from the prior year.
- Current Assets declined to $39.0 million in Q1 2026 per BNGO's latest filing, from $45.4 million in the prior quarter.
- Over five years, Current Assets peaked at $242.4 million in Q1 2022 and troughed at $39.0 million in Q1 2026.
- A 5-year average of $105.7 million and a median of $85.6 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets slumped 71.82% in 2024, then grew 14.93% in 2025.
- Over 5 years, Current Assets stood at $157.3 million in 2022, then dropped by 10.92% to $140.1 million in 2023, then plunged by 71.82% to $39.5 million in 2024, then increased by 14.93% to $45.4 million in 2025, then decreased by 14.13% to $39.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $39.0 million, $45.4 million, and $48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | 24.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.88 Mn |
| Mar 31, 2026 | 38.98 Mn |
| Dec 31, 2025 | 45.39 Mn |
| Sep 30, 2025 | 48.80 Mn |
| Jun 30, 2025 | 42.66 Mn |
| Mar 31, 2025 | 44.93 Mn |
| Dec 31, 2024 | 39.49 Mn |
| Sep 30, 2024 | 46.98 Mn |
| Jun 30, 2024 | 60.57 Mn |
| Mar 31, 2024 | 85.61 Mn |
| Dec 31, 2023 | 140.12 Mn |
| Sep 30, 2023 | 104.54 Mn |
| Jun 30, 2023 | 122.58 Mn |
| Mar 31, 2023 | 142.56 Mn |
| Dec 31, 2022 | 157.30 Mn |
| Sep 30, 2022 | 218.20 Mn |
| Jun 30, 2022 | 216.29 Mn |
| Mar 31, 2022 | 242.36 Mn |
| Dec 31, 2021 | 272.41 Mn |
| Sep 30, 2021 | 342.05 Mn |